BioSpring is a world-leading contract development and manufacturing organization (CDMO) specializing in nucleic acid synthesis and analytics for commercial therapies, clinical therapeutic development, research, and diagnostics. Over the last 28 years, BioSpring has served the pharmaceutical and biotech industry globally with high-quality products and services under cGMP, advancing the development of innovative manufacturing processes and analytical methods. BioSpring continues to be the industry’s go-to partner for high-quality material, supporting clients’ nucleic acid programs from lab to bedside.